Bradley & Co. Private Wealth Management LLC Buys Shares of 277 Danaher Co. (NYSE:DHR)

Bradley & Co. Private Wealth Management LLC bought a new position in Danaher Co. (NYSE:DHR) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 277 shares of the conglomerate’s stock, valued at approximately $64,000.

Several other institutional investors have also modified their holdings of the stock. FFT Wealth Management LLC raised its position in shares of Danaher by 25.8% during the 4th quarter. FFT Wealth Management LLC now owns 3,300 shares of the conglomerate’s stock valued at $758,000 after buying an additional 676 shares during the period. FourThought Financial Partners LLC purchased a new stake in Danaher in the fourth quarter valued at $559,000. Bank of New York Mellon Corp lifted its stake in shares of Danaher by 5.4% in the 4th quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate’s stock valued at $1,971,609,000 after purchasing an additional 441,012 shares during the last quarter. Wrapmanager Inc. lifted its stake in shares of Danaher by 4.2% in the 4th quarter. Wrapmanager Inc. now owns 1,728 shares of the conglomerate’s stock valued at $397,000 after purchasing an additional 69 shares during the last quarter. Finally, Pine Valley Investments Ltd Liability Co grew its holdings in shares of Danaher by 1.4% during the 4th quarter. Pine Valley Investments Ltd Liability Co now owns 9,604 shares of the conglomerate’s stock worth $2,205,000 after purchasing an additional 128 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR opened at $210.65 on Wednesday. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The firm has a market capitalization of $150.56 billion, a price-to-earnings ratio of 39.90, a price-to-earnings-growth ratio of 2.66 and a beta of 0.83. The business’s 50 day simple moving average is $225.79 and its 200-day simple moving average is $246.04. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the business posted $2.09 EPS. As a group, equities analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.32 per share. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.61%. Danaher’s payout ratio is currently 24.24%.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Jefferies Financial Group decreased their target price on shares of Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research report on Wednesday, January 29th. Royal Bank of Canada restated an “outperform” rating and issued a $277.00 price objective (down from $299.00) on shares of Danaher in a report on Thursday, January 30th. Barclays lowered their price objective on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Scotiabank assumed coverage on Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price on the stock. Finally, Guggenheim started coverage on Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 price target for the company. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 11.10% of the stock is owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.